Natural Product: NPC327383

Natural Product IDNPC327383
Common Name
?
The InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
Cryptocaryols A
IUPAC Name (2R)-2-[(2R,4R,6R,8R,10S)-2,4,6,8,10-pentahydroxypentacosyl]-2,3-dihydropyran-6-one
Synonyms
Synthetic Gene Cluster n.a.
ChEMBL Identifier CHEMBL3287577
PubChem CID 71761758
Chemical Classification
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0003909] Fatty Acyls
        • [CHEMONTID:0001334] Fatty alcohols

The Chemical Classification was calculated by Classyfire, a software for chemical taxonomy calculation. Reference: DOI:10.1186/s13321-016-0174-y.

  Chemical Representations

Standard InCHIKey GHNAMLOEGLSFMB-ZHMMVFJOSA-N
Standard InCHI InChI=1S/C30H56O7/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-16-24(31)19-25(32)20-26(33)21-27(34)22-28(35)23-29-17-15-18-30(36)37-29/h15,18,24-29,31-35H,2-14,16-17,19-23H2,1H3/t24-,25+,26+,27+,28+,29+/m0/s1
SMILES CCCCCCCCCCCCCCCC(CC(CC(CC(CC(CC1CC=CC(=O)O1)O)O)O)O)O

  Calculated Properties

Physi-Chem Properties

Molecular Weight:   528.4 Volume:   575.138
?
Van der Waals volume.
Dense:   0.919 LogP:   4.583
?
The logarithm of the n-octanol/water distribution coefficients.
logD7.4:   3.273
?
The logarithm of the n-octanol/water distribution coefficient at pH=7.4.
LogS:   -4.542
?
The logarithm of aqueous solubility value.
Rotatable Bonds:   24.0 Rigid Bonds:   7.0
TPSA:   127.45
?
Topological Polar Surface Area.
H-Bond Acceptor:   7.0
H-Bond Donor:   5.0 Rings:   1.0
Heavy Atoms:   7.0

MedChem Properties

QED Drug-Likeness Score:   0.087 GASA:   1.0
?
GASA represents the probability of being difficult to synthesize, ranging from 0 to 1.
Synthetic Accessibility Score:   4.341 Fsp3:   0.9
MCE-18:   20.702
?
MCE-18 stands for medicinal chemistry evolution.MCE-18≥45 is considered a suitable value.
Lipinski Rule-of-5:   Rejected
Pfizer Rule:   Rejected GSK Rule:   Accepted
Golden Triangle Rule:   Accepted BMS Rule:   1
Chelating Alert:   0 PAINS Alert:   0
Colloidal aggregators:   0.624 Fluc inhibitor:   0.0
?
The fluc inhibitor value is the probability of being fLuc inhibitors, within the range of 0 to 1.
Blue fluorescence:   0.003
?
The blue fluorescence value is the probability of being blue fluorescence, within the range of 0 to 1
Green fluorescence:   0.069
?
The green fluorescence value is the probability of being green fluorescence, within the range of 0 to 1
Reactive compounds:   0.661 Promiscuous compounds:   0.034

ADMET Properties (ADMETlab3.0)

ADMET: Absorption

Caco-2 Permeability:   -5.549 MDCK Permeability:   -4.937
Pgp-inhibitor:   0.0 Pgp-substrate:   0.358
PAMPA:   0.405
?
The experimental data for Peff was logarithmically transformed (logPeff). Molecules with log Peff values below 2.0 were classified as low-permeability (Category 0), while those with log Peff values exceeding 2.5 were classified as high-permeability (Category 1).
Human Intestinal Absorption (HIA):   1.0
20% Bioavailability (F20%):   0.933 30% Bioavailability (F30%):   1.0
50% Bioavailability (F50%):   1.0

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):   0.287 MRP1:   0.744
Plasma Protein Binding (PPB):   99.567% Volume Distribution (VD):   1.236
Fu: 0.979%
?
The fraction unbound in plasms.
OATP1B1 inhibitor:   0.002
OATP1B3 inhibitor:   1.0 BCRP inhibitor:   0.561
BSEP inhibitor:   0.003

ADMET: Metabolism

CYP1A2-inhibitor:   0.0 CYP1A2-substrate:   0.349
CYP2C19-inhibitor:   0.971 CYP2C19-substrate:   0.0
CYP2C9-inhibitor:   0.994 CYP2C9-substrate:   0.961
CYP2D6-inhibitor:   0.0 CYP2D6-substrate:   0.0
CYP3A4-inhibitor:   0.68 CYP3A4-substrate:   0.0
CYP2B6-substrate:   0.0 CYP2C8-inhibitor:   0.876
HLM stability:   0.001
?
Human liver microsomal (HLM) stability. Category 0: stable+ (HLM > 30 min); Category 1: unstable- (HLM ≤ 30 min). The output value is the probability of human liver microsomal instability, where a value closer to 1 indicates a higher likelihood of instability.

ADMET: Excretion

Clearance (CL):  8.136 Half-life (T1/2):  1.364

ADMET: Toxicity

hERG Blockers:  0.799 hERG Blockers (10um):  0.881
Human Hepatotoxicity (H-HT):  0.303 Drug-induced Liver Injury (DILI):  0.007
AMES Toxicity:  0.001 Rat Oral Acute Toxicity:  0.001
Maximum Recommended Daily Dose:  0.84 Skin Sensitization:  0.997
Carcinogencity:  0.008 Eye Corrosion:  0.009
Eye Irritation:  0.437 Respiratory Toxicity:  0.59
Drug-induced Neurotoxicity:  0.005 Ototoxicity:  0.994
Hematotoxicity:  0.016 Drug-induced Nephrotoxicity:  0.987
Genotoxicity:  0.0 RPMI-8226 Immunitoxicity:  0.006
A549 Cytotoxicity:  0.298 Hek293 Cytotoxicity:  0.214
BCF:   1.369
?
Bioconcentration factors are used for considering secondary poisoning potential and assessing risks to human health via the food chain. The unit is -log10[(mg/L)/(1000*MW)].
IGC50:   5.081
?
48 hour Tetrahymena pyriformis IGC50. The unit of IGC50 is -log10[(mg/L)/(1000*MW)].
LC50DM:   6.309
?
48 hour Daphnia magna LC50. The unit of LC50DM is -log10[(mg/L)/(1000*MW)].
LC50FM:   4.285
?
96 hour fathead minnow LC50. The unit of LC50FM is -log10[(mg/L)/(1000*MW)].

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO29906 Cryptocarya Genus Lauraceae Eukaryota n.a. n.a. n.a. PMID[21539301]
NPO29906 Cryptocarya Genus Lauraceae Eukaryota n.a. n.a. n.a. Database[COCONUT]

Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



  NP Quantity Composition/Concentration

Organism ID Organism Name Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



 Biological Activity

Molecular-level activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT4409 Individual protein Programmed cell death protein 4 Homo sapiens Ratio = 3.6 n.a. PMID[24900873]

In vitro activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT83 Cell line MCF7 Homo sapiens IC50 = 8100.0 nM PMID[24900873]
NPT139 Cell line HT-29 Homo sapiens IC50 = 4200.0 nM PMID[24900873]
NPT83 Cell line MCF7 Homo sapiens CI = 0.78 n.a. PMID[24900873]
NPT83 Cell line MCF7 Homo sapiens CI = 1.34 n.a. PMID[24900873]
NPT20529 Non-molecular NON-PROTEIN TARGET n.a. IC50 = 5400.0 nM PMID[24900873]

In vivo activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference





 Experimental ADME

Experiment Model Experiment Tissue ADME Type ADME Relation ADME Value ADME Unit Reference





 Experimental Toxicity

Quantitative toxicity

Experiment Model Experiment Organism Toxicity Type Toxicity Relation Toxicity Value Toxicity Unit Reference

Common Abbreviations:
LC: Lethal Concentration; LD: Lethal Dose; LT:Lethal Time; NOAEL: No-observed-adverse-effect Level; BMDL: Benchmark Dose Lower Confidence Limit; BMD: Benchmark Dose; BMC:Benchmark Concentration; LOAEL: Lowest Observed Adverse Effect Level; RfD:Reference Dose; RfC:Reference Concentration; MRL: Minimal Risk Level; MEG: Maximum Exposure Guideline; PAC: Protective Action Criteria

Categorical toxicity labels

Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption
Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP toxicity records from domain-specific databases. These databases include:
ToxValDB: a curated database that compiles quantitative toxicity values for chemicals from diverse public sources to support toxicological research and risk assessment.
TOXRIC: a comprehensive, free-to-access, online database providing toxicological/feature data. The toxicity labels are retrieved from this database. [PMID: 36400569]


  Chemically structural similarity

Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes approximately 50,000 NPs with experimentally-derived bioactivity available in NPASS)

Similarity is measured using the Tanimoto coefficient (Tc) , which compares the binary fingerprints of two molecules. Tc is calculated as the intersection divided by the union of '1' bits in the fingerprints, ranging from 0 to 1, with 1 indicating highest similarity.

●  The left chart: Distribution of similarity level between NPC327383 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.5 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC185186
0.973 High Similarity NPC481552
0.8684 High Similarity NPC481551
0.7857 Intermediate Similarity NPC481554
0.7857 Intermediate Similarity NPC285840
0.7857 Intermediate Similarity NPC327041
0.7857 Intermediate Similarity NPC481553
0.6809 Remote Similarity NPC481555
0.6667 Remote Similarity NPC180725
0.6667 Remote Similarity NPC248775
0.6522 Remote Similarity NPC489162
0.6522 Remote Similarity NPC489161
0.6522 Remote Similarity NPC489164
0.6522 Remote Similarity NPC489163
0.6327 Remote Similarity NPC470147
0.6327 Remote Similarity NPC470149
0.6327 Remote Similarity NPC470148
0.5897 Remote Similarity NPC159650
0.56 Remote Similarity NPC133226
0.5273 Remote Similarity NPC489473
0.5091 Remote Similarity NPC481543

Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC327383 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.5 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
NPD

Bioactivity similarity

  Bioactivity similarity

Similar Natural Products in NPASS

Similarity level is defined by Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.
Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data